This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Clear Cell Renal Cell Carcinoma or Stage I Renal Cell Cancer
and you are
over 18
years old
0
This is an early phase trial to investigate
how or whether the drug affects your body.
Show me locations

The purpose

This pilot phase 0 trial studies how well enzalutamide works before surgery in treating patients with kidney cancer. Androgens are a type of hormone produced by the body that may cause kidney tumors to grow. Anti-hormone therapy, such as enzalutamide, may lessen the amount of androgens produced by the body and keep kidney tumors from growing.

Provided treatments

  • Drug: Enzalutamide
  • Other: Laboratory Biomarker Analysis
  • Procedure: Nephrectomy

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02885649. The sponsor of the trial is Rutgers, The State University of New Jersey and it is looking for 3 volunteers for the current phase.
Official trial title:
Pilot Study of the Blockade of Androgens in Renal Cell Carcinoma Using Enzalutamide (BARE)